Sentence examples for mortality the use from inspiring English sources

Despite this significant morbidity and mortality, the use of diagnostic testing (both noninvasive and invasive testing) in the year prior to LEA is low and varies based on patient, provider, and regional factors.

In prospective studies in adult populations, this single measure has shown predictive power for later morbidity, mortality, the use of health services, and disability pensioning.

In cancer, when early detection is critical to reducing morbidity and mortality, the use of molecule specific contrast agents provides the ability to optically sense and image abnormalities long before pathologic changes occur at the anatomic level [ 15].

Considering the increased risk of death due to increased hypoglycemia and the findings that intensive insulin therapy does not reduce mortality, the use of IIT as a strategy to maintain normoglycemia remains unclear.

Our sensitivity analyses suggest that, at least for mortality, the use of heatwave metrics designed to reflect multiple day events that meet detailed heatwave criteria produce broadly similar results to those found with single day heat metrics such as maximum daily air temperature, or a simple 3 day moving average.

The multivariate analysis identified three factors independently associated with higher MICU mortality: the use of vasoactive agents (odds ratio [OR] 6.81, 95%confidence interval [95%CI] 1.77-26.26, p = 0.005), requirement for mechanical ventilation (OR 6.61 95% CI [1.44-30.5], p = 0.015) and platelet count below 100,000/mm3 (OR 5.13, 95%CI [1.17-22.5]; p = 0.030).

Analysis of mortality and risk factors for mortality in the use of renal replacement therapy to correct metabolic disturbances associated with confirmed or suspected inborn errors of metabolism.

Septic shock is associated with significant mortality despite the use of appropriate antibiotics, adequate resuscitation, and modern intensive care [1].

The increased mortality from the use of these drugs for prophylaxis of cardiac arrhythmias has forced a re-evaluation of their use and of the entire pharmacological strategy of arrhythmia management.

In the executive summary, it recommends that "the potential for behavioral responses and indirect injury or mortality from the use of similar MBES systems should be considered in future environmental assessments, operational planning, and regulatory decisions".

The pooled OR for mortality with the use of aPC was 0.67 (95% CI 0.62 to 0.72).